Proteinase 3 (PR3) and myeloperoxidase (MPO) are the primary targets of the c- and p-ANCA in AAV patients, respectively; PR3 is most commonly associated with GPA, while MPO is more frequently linked to MPA (4). The gene discussed is MPO; the disease is anti-neutrophil cytoplasmic antibody-associated vasculitis.